ALDX
#3980
Aldeyra Therapeutics, Inc. - Common Stock
1.4 8 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.67%
Variación mensual
-4.52%
Variación en los últimos 6 meses
-72.59%
Cambio anual
-74.57%
Cierres anteriores
1.4 8
Open
1.4 6
Mínimo
1.4 6
Máximo
1.4 8
Volumen
65
Financials
- Market Capitalization 89.28 M
- Employee 6
- Founded 2004
- CEO Todd C. Brady M.D., Ph.D.
- Website www.aldeyra.com
- Headquarter Delaware, United States
- FIGI BBG0029H8ZF6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.61
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3977 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 2.06 USD | -1.44% | -6.79% | +35.53% | +57.25% | 88.28 M USD | ||
| 3979 |  ATRA Atara Biotherapeutics, Inc. - Common Stock | 8.98 USD | +0.90% | -6.65% | +6.65% | -39.12% | 90.14 M USD | ||
| 3981 |  RLYB Rallybio Corporation - Common Stock | 16.79 USD | -0.12% | -1.12% | +5.20% | +3128.85% | 89.16 M USD | ||
| 3984 |  ICCC ImmuCell Corporation - Common Stock | 10.02 USD | +2.35% | +2.56% | -11.56% | +59.30% | 91.00 M USD |